Peer-reviewed study highlights high potential for cell-penetrating peptides in mRNA-based cancer treatments Demonstrates effective uptake…
LAWRENCEVILLE, N.J., July 19, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), a clinical-stage company focused…
MALVERN, Pa., July 19, 2022 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage…
– Novan and Evening Post Group enter into a loan payoff and termination agreement, fully…
NEW YORK, July 19, 2022 (GLOBE NEWSWIRE) — Better Choice Company Inc. (NYSE: BTTR) (the…
Data show that 71% of 24 patients with recurrent vulvovaginal candidiasis (RVVC) who failed to…
Michael H. Tardugno appointed Executive Chairman of the Board LAWRENCEVILLE, N.J., July 19, 2022 (GLOBE…
Kabir Nath will build upon COMPASS’ success and lead the development of novel models of…
Oryzon and NCI will collaborate to assess the safety and efficacy of iadademstat in oncology…
CALM 201 Study to Explore the Safety and Efficacy of Single 5mg-Dose INP105 Compared to…
– Analyses Demonstrate CT1812 Impact on Alzheimer’s Disease Processes – NEW YORK, July 19, 2022…
CannaNova Cannabinoid Film Cannabinoid Film (CannaNova) Greensboro, NC, July 19, 2022 (GLOBE NEWSWIRE) — CannaNova…
BRIDGEWATER, N.J., July 19, 2022 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or…
OREM, Utah, July 19, 2022 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (Symbol: RSCF), a provider…
DURHAM, N.C., July 19, 2022 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology…
NEWTON, Mass., July 19, 2022 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) (“Allena” or…
Reiterates the Board’s Commitment to Expeditiously Distributing All of the Company’s Available Cash to Stockholders,…
Webcast and Conference Call to Be Held Tuesday, August 2, 2022 at 8:30 a.m. EDT…
PDUFA target action date is November 26, 2022 FDA has stated that it is not…
Indication demonstrates NeuroStar TMS safety and efficacy in improving anxiety symptoms in depressed patients MALVERN,…